Exagen Balance Sheet Health
Financial Health criteria checks 4/6
Exagen has a total shareholder equity of $12.9M and total debt of $20.3M, which brings its debt-to-equity ratio to 157.4%. Its total assets and total liabilities are $43.6M and $30.7M respectively.
Key information
157.4%
Debt to equity ratio
US$20.25m
Debt
| Interest coverage ratio | n/a |
| Cash | US$22.04m |
| Equity | US$12.87m |
| Total liabilities | US$30.74m |
| Total assets | US$43.61m |
Recent financial health updates
Is Exagen (NASDAQ:XGN) Using Debt In A Risky Way?
May 21
Exagen (NASDAQ:XGN) Has Debt But No Earnings; Should You Worry?
Jul 26Is Exagen (NASDAQ:XGN) Weighed On By Its Debt Load?
Apr 05Does Exagen (NASDAQ:XGN) Have A Healthy Balance Sheet?
Dec 03Does Exagen (NASDAQ:XGN) Have A Healthy Balance Sheet?
Aug 06Recent updates
Improved Revenues Required Before Exagen Inc. (NASDAQ:XGN) Stock's 40% Jump Looks Justified
Sep 06Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Second-Quarter Report
Aug 07Insufficient Growth At Exagen Inc. (NASDAQ:XGN) Hampers Share Price
Jul 13Is Exagen (NASDAQ:XGN) Using Debt In A Risky Way?
May 21Why Investors Shouldn't Be Surprised By Exagen Inc.'s (NASDAQ:XGN) 31% Share Price Plunge
Mar 26Analysts Have Made A Financial Statement On Exagen Inc.'s (NASDAQ:XGN) Annual Report
Mar 22Exagen Inc.'s (NASDAQ:XGN) Business And Shares Still Trailing The Industry
Jul 21Exagen appoints John Aballi as CEO
Oct 17Analysts Just Slashed Their Exagen Inc. (NASDAQ:XGN) EPS Numbers
Aug 10Exagen (NASDAQ:XGN) Has Debt But No Earnings; Should You Worry?
Jul 26Is Exagen (NASDAQ:XGN) Weighed On By Its Debt Load?
Apr 05Does Exagen (NASDAQ:XGN) Have A Healthy Balance Sheet?
Dec 03Does Exagen (NASDAQ:XGN) Have A Healthy Balance Sheet?
Aug 06Exagen Inc.'s (NASDAQ:XGN) Intrinsic Value Is Potentially 62% Above Its Share Price
Apr 07Is Exagen (NASDAQ:XGN) Using Too Much Debt?
Mar 03Exagen issues preliminary testing revenue ahead of ICT chat
Jan 11Would Shareholders Who Purchased Exagen's (NASDAQ:XGN) Stock Year Be Happy With The Share price Today?
Jan 05Exagen (XGN) Investor Presentation - Slideshow
Nov 20Financial Position Analysis
Short Term Liabilities: XGN's short term assets ($35.6M) exceed its short term liabilities ($8.8M).
Long Term Liabilities: XGN's short term assets ($35.6M) exceed its long term liabilities ($22.0M).
Debt to Equity History and Analysis
Debt Level: XGN has more cash than its total debt.
Reducing Debt: XGN's debt to equity ratio has increased from 43.8% to 157.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XGN has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if XGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.